(NASDAQ: AXGN) Axogen's forecast annual revenue growth rate of 19.47% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.03%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.15%.
Axogen's revenue in 2026 is $266,926,000.On average, 13 Wall Street analysts forecast AXGN's revenue for 2026 to be $17,627,131,304, with the lowest AXGN revenue forecast at $16,353,075,153, and the highest AXGN revenue forecast at $18,244,746,897. On average, 13 Wall Street analysts forecast AXGN's revenue for 2027 to be $22,593,740,256, with the lowest AXGN revenue forecast at $19,868,825,038, and the highest AXGN revenue forecast at $24,666,993,374.
In 2028, AXGN is forecast to generate $27,087,879,253 in revenue, with the lowest revenue forecast at $23,842,709,507 and the highest revenue forecast at $29,288,956,100.